No Data
No Data
Mewah International (SGX:MV4) Shareholders Have Endured a 35% Loss From Investing in the Stock Three Years Ago
Mewah International Appoints New Deputy Chief Executive Officer
Mewah International (SGX:MV4) appointed Bianco Cheo Hui Hsin as the company's deputy chief executive officer, with effect from May 14, according to a filing with the Singapore Exchange on Tuesday. She
Individual Investors Own 24% of Mewah International Inc. (SGX:MV4) Shares but Private Companies Control 55% of the Company
Meihua International Medical Technology Co., Ltd. announces 2023 financial results
Yangzhou, April 24, 2024/PRNewswire/ -- Meihua International Medical Technology Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA), a reputable manufacturer and supplier of Class I, II, and Class III disposable medical devices with operating subsidiaries in China, today announced financial results for the full year ended December 31, 2023. All amounts below are in US dollars. Financial highlights for the full year of 2023: Revenue remained stable and fell slightly by 6% to $97.1 million in 2023, compared to $103.3 million in 2022
Mewah International (SGX:MV4) Shareholders Will Want The ROCE Trajectory To Continue
With EPS Growth And More, Mewah International (SGX:MV4) Makes An Interesting Case
No Data